Elanco

We are proud to announce that Bobby (Rajeev) Modi, Elanco Executive Vice President, U.S. Pet Health, has been elected to the Animal Health Institute’s (AHI) newly reestablished Executive Committee. AHI represents the innovators behind animal medicines—an industry that supports the health of nearly 10 billion pets and livestock in the U.S. alone. Beyond animal care, our industry serves as a cornerstone of global public health and economic stability. From ensuring a safe and sustainable protein supply to protecting the vital bond between people and their pets, the relevance of animal health has never been more critical. As a Board member, Bobby will support AHI's work to advocate for efficient, science-based pathways that accelerate the delivery of new solutions to the market. By modernizing these regulatory frameworks, we can ensure veterinarians, farmers and pet owners have faster access to the medicines and technologies needed to support long, healthy lives for the animals we love. We look forward to the efforts to advance much needed progress.

When it comes to killing ticks, speed matters. New data published in Parasites & Vectors shows that Credelio Quattro™ kills black-legged ticks within just 8 hours(1)—significantly faster(2) than leading competitors. The active ingredient lotilaner in Credelio Quattro also kills lone star ticks within 12 hours of infestation, the fastest(3) initial speed of tick kill compared to competitors(4). Lyme disease transmission typically occurs 24-48 hours after attachment(1). A rapid and consistent speed of kill is the critical factor in pet protection. While other products show a decline in performance by the end of the month, lotilaner maintains its 8-hour speed of kill through Day 28(2). Read the full study here: https://bit.ly/4fe0f7w View the full Credelio Quattro/Credelio Quattro-CA product label at CredelioQuattroLabel.com. PM-US-26-1304 1. Reif, K.E., Kollasch, T.M., Locklear, C.L. et al. Comparative speed of kill of induced Ixodes scapularis infestations following treatment of dogs with endectocides containing either sarolaner (Simparica Trio™), afoxolaner (NexGard® PLUS), or lotilaner (Credelio Quattro™). Parasites Vectors (2026). https://lnkd.in/ewpdHJdx 2. Based on the time to statistical significance vs. control in a head-to-head study on Day 0 post-treatment and Day 28 for reinfestations comparing Credelio Quattro, which contains lotilaner as well as moxidectin, praziquantel, and pyrantel—to the active ingredients in Simparica Trio® (sarolaner, moxidectin, and pyrantel) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel) against Ixodes scapularis. 3. Based on the time to statistical significance vs control in a head-to-head study comparing Credelio (lotilaner)—not Credelio Quattro, which contains lotilaner as well as moxidectin, praziquantel, and pyrantel—to the active ingredients in Simparica Trio® (sarolaner, moxidectin, and pyrantel) and NexGard® (afoxolaner). 4. Reif KE, Kollasch TM, Neilson JC, Herrin BH, Ryan WG, Bell MC, Beltz MS, Dryden MW, Jesudoss Chelladurai JRJ, Miller KR, Sutherland CJ. Comparative speed of kill provided by lotilaner (Credelio™), sarolaner (Simparica Trio™), and afoxolaner (NexGard™) to control Amblyomma americanum infestations on dogs. Parasit Vectors. 2024 Jul 20;17(1):313.

From diverting 75.9% of construction waste from landfills to saving over 542,000 gallons of water annually through high-efficiency facilities, every design choice at our headquarters in Indianapolis was intentional. We've prioritized sustainable material sourcing and partnered with organizations like Purposeful Designs to ensure our social impact is as profound as our environmental one. By investing in an eco-conscious and employee-friendly campus, we are ensuring that our physical environment supports our mission to improve the lives of animals and the health of our planet.

Our team is heading to #AVMA2026 next week! Join us for six sponsored CE sessions where speakers will dive into the latest in: - Vaccine Hesitancy & Leptospirosis - Osteoarthritis Management - Dermatology & Pruritus Mastery - Fast-acting Tick Protection Each session will be led by experts who share your passion for animal health. Interested in attending? Learn more about AVMA (American Veterinary Medical Association) and see the full schedule here: https://bit.ly/4xd0XZz

Earlier today, veterinary professionals and media contacts may have received unusual communications connected to Elanco's celebration of National Take Your Cat To Work Day. While the earlier messages may have been difficult to interpret, the intended message behind them remains the same: Credelio® CAT (lotilaner) is specifically designed for cats. For more information about Credelio Cat and its uniquely palatable formulation, visit https://lnkd.in/eb5yXDaD.

During Global Volunteer Month, we paused to recognize something we value year-round: the importance of volunteerism. We’ve set a goal of 30,000 volunteer hours in 2026 and here are some of the ways our employees are currently making impact in their community.

Innovation isn’t just a goal—it’s an investment in the future of animal health. We are excited to announce plans to establish Elanco Ventures, a dedicated corporate venture capital platform to be backed by a $25 million multi-year commitment to accelerate innovation in animal health. Elanco Ventures will gain early visibility into emerging technologies that address the world’s most pressing challenges—from the evolving expectations of pet owners to the rising global demand for sustainable protein. Initially focusing on early-stage therapeutics, we are also looking toward the broader One Health landscape. Anchored by our partnership in the One Health Innovation District in Indianapolis, we are bridging the gap between bold ideas and global impact. Our industry is more relevant than ever before and we're excited to accelerate innovation that makes life better. Learn more here: https://bit.ly/4uMnWsa

Nothing says summer like a scoop of ice cream—but the impact of the dairy industry goes far beyond the cone. Dairy products are a cornerstone of global nutrition and a vital economic driver. As we celebrate National Dairy Month, Elanco remains committed to supporting dairy producers with the innovations they need to improve cow health, enhance milk quality and meet the growing global demand for sustainable protein.

Now approved: TruCan™ Ultra Lyme-L4, the first and only 1/2 mL combination vaccine protecting against both Lyme disease and leptospirosis in a single dose. Approved by the USDA, this milestone expands our extensive TruCan™ Ultra Portfolio and provides veterinarians with a powerful tool to help close critical protection gaps. With leptospirosis vaccine now recognized as a core vaccine(1) and Lyme disease spreading to new geographies(2), this 1/2 mL formulation offers broad protection in half the volume of traditional vaccines. TruCan™ Ultra Lyme-L4 features our proprietary PureFil™ Technology, that removes extraneous proteins, designed to lower the risk of  vaccine-associated adverse events (VAAEs)(3-5). Learn more here: https://bit.ly/4vO2lR5 (1) AAHA Guidelines (2) Eisen RJ, Eisen L, Beard CB. County-Scale Distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the Continental United States. J Med Entomol. 2016 Mar;53(2):349-86. doi: 10.1093/jme/tjv237. (3) Elanco Animal Health. Data on File. REF-29478 (4) Franco J, Aryal UK, HogenEsch H, Moore GE. Proteomic analysis of canine vaccines. Am J Vet Res. 2023;84(3):ajvr.22.11.0192. Published 2023 Jan 24. doi:10.2460/ajvr.22.11.0192 (5) Ohmori K, Masuda K, Maeda S, et al. IgE reactivity to vaccine components in dogs that developed immediate type allergic

Family Day at Victory Field was a chance to step back and celebrate our collective achievements. Thank you to everyone who joined us! #WeAreElanco